"To improve the bioavailability of curcumin, numerous approaches have been undertaken. These approaches involve, first, the use of adjuvant like piperine that interferes with glucuronidation; second, the use of liposomal curcumin; third, curcumin nanoparticles; fourth, the use of curcumin phospholipid complex; and fifth, the use of structural analogues of curcumin"The article is by Bharat Aggarwal, who first demonstrated that curcumin inhibits NfkB. The strategy can likely be used for other compounds too.
Why I'm Marching for Science
20 hours ago in Angry by Choice